Other articles

ACC 2019 | POET: los antibióticos vía oral con buenos resultados a largo plazo en endocarditis

ACC 2019 | POET: Oral Antibiotics with Good Long-Term Results for Endocarditis

ACC 2019 | POET: Oral Antibiotics with Good Long-Term Results for Endocarditis

This work found better survival rates with oral treatment, an outcome that may be credited to shorter hospital stays and the subsequent reduction of complications related to them. A strategy of switching to oral treatment after a short intravenous (IV) regimen confers long-term safety and efficacy. These data are derived from an exploratory analysis of

Evolución de pacientes jóvenes con miocardiopatía hipertrófica tratados con ablación septal por alcoholización.

Contemporary Results for Septal Embolization in Hypertrophic Cardiomyopathy

This work showed that percutaneous septal ablation in patients with symptomatic hypertrophic cardiomyopathy is safe (and improves patient symptoms) and results in excellent long-term survival. Alcohol-induced infarction for treatment of symptomatic hypertrophic obstructive cardiomyopathy is controversial because, while it may relieve acute symptoms, it might also increase long-term mortality.   This study sought to report

Disminuye la profilaxis de endocarditis luego de las guías del 2007

AHA 2018 | Endocarditis Prophylaxis More Limited after AHA 2007 Guidelines

The incidence of infective endocarditis had decreased after AHA 2007 recommendations. At present, some patients are not receiving antibiotic prophylaxis as they should. After AHA restricted the use of antibiotic prophylaxis in 2007, high-risk patients undergoing dental procedures were prescribed less antibiotics. These patients had always been prescribed antibiotic prophylaxis, regardless they had less restrictive

REDUCE Trial: Pacientes con FOP y ACV criptogénico tienen menor riesgo de ACV recurrente cuando son tratados con terapia antiplaquetaria y dispositivos de cierre

SOLACI-SOCIME 2018 | When Not to Use a Device: Characteristics of Atrial Septal Defects that Do Not Lead to Percutaneous Closure

Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. In this case see the presentation of Dr. Lee Benson, entitled “When Not to Use a Device: Characteristics of Atrial Septal Defects that Do Not Lead to Percutaneous Closure”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc.,

DEFENSE-PFO: el cierre FOP con ciertas características disminuye eventos combinados y stroke

DEFENSE-PFO: High Risk PFO Closure Reduces Combined Events and Stroke Risk

High risk patent foramen ovale closure PFO resulted in reduced stroke, vascular death and bleeding risk. Recent reports have shown a favorable role of PFO in patients with cryptogenic stroke, though with some unclear results, which immediately raised the questions: Who are the optimal candidates for this procedure, and who will see no benefit?

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen oval

Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated

Cryptogenic stroke patients with migraine have high prevalence (79%) of patent foramen ovale (PFO) with right to left shunt. However, the timing of stroke in migraineurs is not usually associated to a migraine attack. These observations are consistent with the hypothesis that the most likely mechanism of stroke in these patients with migraine is a

ACC 2018 | Flu Vaccination Reduces Mortality in Heart Failure Hospitalizations

Heart failure patients vaccinated against influenza are at a significantly lower risk of dying, both during flu season and outside of it. Patients with heart failure vaccinated had a 48% lower risk of death during influenza season and a 21% lower risk during the rest of the year. Dr. Fukuta, lead investigator in this study,

ACC 2018 | Echocardiographic Data Help Better Choose Patients for Patent Foramen Ovale Closure

A new randomized controlled trial of patients who underwent patent foramen ovale (PFO) closure in cryptogenic stroke may provide certain morphological echocardiographic features that might allow us to better choose patients who would benefit more from PFO closure versus those for whom medical therapy would be more appropriate. Among patients with a recent cryptogenic stroke

Resultados a 5 años del cierre de orejuela

Five-Year Outcomes for Appendage Closure

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial appendage closure with the Watchman device was equivalent to warfarin for preventing stroke in atrial fibrillation, but it had a high rate of peri-procedural complications. The follow-up randomized trial was PREVAIL (Evaluation of the

Casos Complejos

Complex Cases at SOLACI-CACI 2017 Congress

Complex Cases at SOLACI-CACI 2017 Congress. Presenters: Dr. Carlos Calderas, Venezuela.  Dr. Luis Gutierrez Jaikel, Costa Rica.  Dr. Fernando Pineda, Chile. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch them  We are

Radioprotection: 6 essential articles to keep you updated

1) On Radiation Protection: Editorial comment by Dr. Ariel Durán I am pleased to witness the increased amount of scientific papers in high impact journals addressing topics related to radiation protection or the harmful effects of radiation on our patients and primary or secondary operators. Similarly, it is my pleasure to see that SOLACI has